Insulet Corporation
Save
11.64B
Market cap
56.53x
Current P/E
61.73x
Forward P/E
About
Health care
Sector
Medical - Devices
Industry
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia.
Similar securities
Based on sector and market capitalization
Report issue